Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Hepatitis C virus (HCV) prevalence estimation in the adult general population in Belgium : a meta-analysis.

Muyldermans G, Bielen R, Botterman R, Bourgeois S, Colle I, Deressa B, Devolder G, Horsmans Y, Hutse V, Lanthier N, Lasser L, Platteau S, Robaeys G, Suin V, Verhelst X, Van Vlierberghe H, Van Baelen L.

Acta Gastroenterol Belg. 2019 Oct-Dec;82(4):479-485.

PMID:
31950802
2.

Diagnostic hepatitis C testing of people in treatment for substance use disorders in Belgium between 2011 and 2014 : a cross-sectional study.

Van Baelen L, Antoine J, De Ridder K, Muyldermans G, Gremeaux L.

Acta Gastroenterol Belg. 2019 Jan-Mar;82(1):35-42.

PMID:
30888752
3.

Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.

Litzroth A, Suin V, Wyndham-Thomas C, Quoilin S, Muyldermans G, Vanwolleghem T, Kabamba-Mukadi B, Verburgh V, Jacques M, Van Gucht S, Hutse V.

BMC Public Health. 2019 Jan 8;19(1):39. doi: 10.1186/s12889-018-6347-z.

4.

Distribution of HCV genotypes in Belgium from 2008 to 2015.

Bouacida L, Suin V, Hutse V, Boudewijns M, Cartuyvels R, Debaisieux L, De Laere E, Hallin M, Hougardy N, Lagrou K, Oris E, Padalko E, Reynders M, Roussel G, Senterre JM, Stalpaert M, Ursi D, Vael C, Vaira D, Van Acker J, Verstrepen W, Van Gucht S, Kabamba B, Quoilin S, Muyldermans G.

PLoS One. 2018 Dec 5;13(12):e0207584. doi: 10.1371/journal.pone.0207584. eCollection 2018.

5.

Surveillance of Infectious Diseases by the Sentinel Laboratory Network in Belgium: 30 Years of Continuous Improvement.

Muyldermans G, Ducoffre G, Leroy M, Dupont Y, Quolin S; participating sentinel laboratories.

PLoS One. 2016 Aug 29;11(8):e0160429. doi: 10.1371/journal.pone.0160429. eCollection 2016.

6.

Assessing the sensitivity and representativeness of the Belgian Sentinel Network of Laboratories using test reimbursement data.

Berger N, Muyldermans G, Dupont Y, Quoilin S.

Arch Public Health. 2016 Aug 8;74:29. doi: 10.1186/s13690-016-0145-9. eCollection 2016.

7.

HIV-1 resistance and trend analysis in newly diagnosed patients in Belgium.

Muyldermans G, Sasse A.

Acta Clin Belg. 2014 Jan-Feb;69(1):1-7. doi: 10.1179/0001551213Z.0000000001.

PMID:
24635391
8.

Correction: Establishment and reinforcement of the National Reference Centers for Human Microbiology in Belgium.

Muyldermans G, Litzroth A, Ducoffre G, Quoilin S; Medical-Technical Advisory Board.

Arch Public Health. 2013 Apr 22;71(1):8. doi: 10.1186/0778-7367-71-8. No abstract available.

9.

Establishment and reinforcement of the national reference centers for human microbiology in Belgium.

Muyldermans G, Litzroth A, Ducoffre G, Quoilin S; Medical-Technical Advisory Board.

Arch Public Health. 2012 Jun 22;70(1):16. doi: 10.1186/0778-7367-70-16. Erratum in: Arch Public Health. 2013(1);71:8. Gaëtan, Muyldermans [correct to Muyldermans, Gaëtan]; Amber, Litzroth [correct to Litzroth, Amber]; Geneviève, Ducoffre [correct to Ducoffre, Geneviève]; Sophie, Quoilin [correct to Quoilin, Sophie].

10.

The impact of individual human immunodeficiency virus type 1 protease mutations on drug susceptibility is highly influenced by complex interactions with the background protease sequence.

Van Marck H, Dierynck I, Kraus G, Hallenberger S, Pattery T, Muyldermans G, Geeraert L, Borozdina L, Bonesteel R, Aston C, Shaw E, Chen Q, Martinez C, Koka V, Lee J, Chi E, de Béthune MP, Hertogs K.

J Virol. 2009 Sep;83(18):9512-20. doi: 10.1128/JVI.00291-09. Epub 2009 Jul 8.

11.

Production of recombinant antigens of Ureaplasma parvum serotypes 3 and 6 for development of a serological assay.

Vancutsem E, Echahidi F, Van Geel K, Muyldermans G, Soetens O, Naessens A.

Clin Vaccine Immunol. 2008 Mar;15(3):447-51. Epub 2007 Dec 19.

12.

External quality assessment for molecular detection of Bordetella pertussis in European laboratories.

Muyldermans G, Soetens O, Antoine M, Bruisten S, Vincart B, Doucet-Populaire F, Fry NK, Olcén P, Scheftel JM, Senterre JM, van der Zee A, Riffelmann M, Piérard D, Lauwers S.

J Clin Microbiol. 2005 Jan;43(1):30-5.

13.

Simple Algorithm for Identification of Bordetella pertussis Pertactin Gene Variants.

Muyldermans G, Piérard D, Hoebrekx N, Advani R, Van Amersfoorth S, De Schutter I, Soetens O, Eeckhout L, Malfroot A, Lauwers S.

J Clin Microbiol. 2004 Apr;42(4):1614-9.

14.

Prevalence of fragilysin gene in Bacteroides fragilis isolates from blood and other extraintestinal samples.

Foulon I, Piérard D, Muyldermans G, Vandoorslaer K, Soetens O, Rosseel P, Lauwers S.

J Clin Microbiol. 2003 Sep;41(9):4428-30.

15.

Molecular typing of Bordetella pertussis isolates recovered from Belgian children and their household members.

De Schutter I, Malfroot A, Dab I, Hoebrekx N, Muyldermans G, Piérard D, Lauwers S.

Clin Infect Dis. 2003 Jun 1;36(11):1391-6. Epub 2003 May 21.

PMID:
12766833
16.

Recovery of Mycobacterium elephantis from sputum of a patient in Belgium.

Potters D, Seghers M, Muyldermans G, Piérard D, Naessens A, Lauwers S.

J Clin Microbiol. 2003 Mar;41(3):1344. No abstract available.

17.

Prevalence of genotypic resistance among antiretroviral drug-naive HIV-1-infected patients in Belgium.

Van Vaerenbergh K, Debaisieux L, De Cabooter N, Declercq C, Desmet K, Fransen K, Maes B, Marissens D, Miller K, Muyldermans G, Sprecher S, Stuyver L, Vaira D, Verhofstede C, Zissis G, Van Ranst M, De Clercq E, Desmyter J, Vandamme AM.

Antivir Ther. 2001 Mar;6(1):63-70.

PMID:
11417763
18.

Blinded, multicenter quality control study for the quantification of human immunodeficiency virus type 1 RNA in plasma by the Belgian AIDS reference laboratories.

Muyldermans G, Debaisieux L, Fransen K, Marissens D, Miller K, Vaira D, Vandamme AM, Vandenbroucke AT, Verhofstede C, Schuurman R, Zissis G, Lauwers S.

Clin Microbiol Infect. 2000 Apr;6(4):213-7.

19.

Development of an enzyme-linked immunosorbent assay for serotyping ureaplasma urealyticum strains using monoclonal antibodies.

Echahidi F, Muyldermans G, Lauwers S, Naessens A.

Clin Diagn Lab Immunol. 2001 Jan;8(1):52-7.

20.

Outbreak of necrotizing enterocolitis associated with Enterobacter sakazakii in powdered milk formula.

van Acker J, de Smet F, Muyldermans G, Bougatef A, Naessens A, Lauwers S.

J Clin Microbiol. 2001 Jan;39(1):293-7.

21.

Development of monoclonal antibodies against Ureaplasma urealyticum serotypes and their use for serotyping clinical isolates.

Echahidi F, Muyldermans G, Lauwers S, Naessens A.

Clin Diagn Lab Immunol. 2000 Jul;7(4):563-7.

22.

Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapy.

Van Vaerenbergh K, Van Laethem K, Van Wijngaerden E, Schmit JC, Schneider F, Ruiz L, Clotet B, Verhofstede C, Van Wanzeele F, Muyldermans G, Simons P, Stuyver L, Hermans P, Evans C, De Clercq E, Desmyter J, Vandamme AM.

AIDS Res Hum Retroviruses. 2000 Apr 10;16(6):529-37.

PMID:
10777143
23.

Identification of new verocytotoxin type 2 variant B-subunit genes in human and animal Escherichia coli isolates.

Piérard D, Muyldermans G, Moriau L, Stevens D, Lauwers S.

J Clin Microbiol. 1998 Nov;36(11):3317-22.

24.

Neonatal infections with Pseudomonas aeruginosa associated with a water-bath used to thaw fresh frozen plasma.

Muyldermans G, de Smet F, Pierard D, Steenssens L, Stevens D, Bougatef A, Lauwers S.

J Hosp Infect. 1998 Aug;39(4):309-14.

PMID:
9749402
25.

False-negative HIV viral load in AIDS patients.

Simons P, Muyldermans G, Lacor P, Zissis G, Lauwers S.

AIDS. 1997 Nov 15;11(14):1783-4. No abstract available.

PMID:
9386817
26.

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.

Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, Parmentier M.

Nature. 1996 Aug 22;382(6593):722-5.

PMID:
8751444
27.

Expression in E. coli and purification of the active autoprotease P20 of classical swine fever virus.

Muyldermans G, San Gabriel MC, Hamers R, Wyns L.

Virus Genes. 1996;13(2):135-42.

PMID:
8972567
28.

Polymerase chain reaction-mediated cloning and in vitro translation of the genes coding for the structural proteins of hog cholera virus.

Muyldermans G, San Gabriel MC, Caij A, De Smet A, Hamers R.

Arch Virol. 1993;132(3-4):429-35.

PMID:
8397504
29.

Production and characterization of monoclonal antibodies against hog cholera virus (Alfort 187 strain).

Caij A, Muyldermans G, De Smet A, Hamers R, Koenen F.

Arch Virol. 1993;131(1-2):185-92. No abstract available.

PMID:
8328912
30.

Serological and antigenical findings indicating pestivirus in man.

Giangaspero M, Vacirca G, Buettner M, Wolf G, Vanopdenbosch E, Muyldermans G.

Arch Virol Suppl. 1993;7:53-62.

PMID:
8219813
31.

Characterization of structural and non-structural proteins of hog cholera virus by means of monoclonal antibodies.

Muyldermans G, Caij A, De Smet A, Koenen F, Hamers R.

Arch Virol. 1993;131(3-4):405-17.

PMID:
7688508
32.

Competitive antagonists of the action of diphtheria toxin in HeLa cells.

Zanen J, Muyldermans G, Beugnier N.

FEBS Lett. 1976 Jul 15;66(2):261-3. No abstract available.

33.

[Proceedings: Biological activity of diphtheria toxin fragment B].

Muyldermans G, Zanen J.

Arch Int Physiol Biochim. 1976 Feb;84(1):178-9. French. No abstract available.

PMID:
60950
34.

[Microcomplement fixation test applied to a diphtheria toxin-antitoxin system].

Muyldermans G, Zanen J.

Arch Int Physiol Biochim. 1974 Feb;82(1):190. French. No abstract available.

PMID:
4136405

Supplemental Content

Loading ...
Support Center